Cargando…

Potential antitumor effects of nitrogen-containing bisphosphonate in hormone receptor negative breast cancer patients with bone metastases

BACKGROUND: This retrospective study evaluated, according to hormone receptor status, the antitumor effects of bisphosphonate especially on survival and disease progression in breast cancer patients with metastatic bone disease. METHODS: Of 317 patients with initial bone metastasis and known breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, In Hae, Ro, Jungsil, Nam, Byung Ho, Kwon, Youngmi, Lee, Keun Seok
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694816/ https://www.ncbi.nlm.nih.gov/pubmed/19454038 http://dx.doi.org/10.1186/1471-2407-9-154

Ejemplares similares

Breast cancer subtypes and survival in patients with brain metastases
por: Nam, Byung-Ho, et al.
Publicado: (2008)

Bisphosphonates and bone metastases.
por: Morton, A. R., et al.
Publicado: (1988)

Bisphosphonates enhance antitumor effect of EGFR-TKIs in patients with advanced EGFR mutant NSCLC and bone metastases
por: Zhang, Guowei, et al.
Publicado: (2017)

Outcomes of Palliative Weekly Low-Dose Gemcitabine-Cisplatin Chemotherapy in Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer Patients
por: Kim, Jung Sun, et al.
Publicado: (2014)

Anti-cancer effects of nitrogen-containing bisphosphonates on human cancer cells
por: Jiang, Pengfei, et al.
Publicado: (2016)

The Effects of Long-term Use of Nitrogen-containing Bisphosphonates on Fracture Healing
por: Begkas, Dimitrios, et al.
Publicado: (2019)

Nitrogen Containing Bisphosphonates Impair the Release of Bone Homeostasis Mediators and Matrix Production by Human Primary Pre-Osteoblasts
por: Giannasi, Chiara, et al.
Publicado: (2019)

Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.
por: Walls, J., et al.
Publicado: (1994)

Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases
por: Aapro, Matti, et al.
Publicado: (2010)

Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases
por: Pfannkuchen, Nina, et al.
Publicado: (2017)

Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells
por: Forsea, A-M, et al.
Publicado: (2004)

Identification of a transporter complex responsible for the cytosolic entry of nitrogen-containing bisphosphonates
por: Yu, Zhou, et al.
Publicado: (2018)

Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
por: Polascik, Thomas J
Publicado: (2009)

Analysis of the Mechanism and Safety of Bisphosphonates in Patients with Lung Cancer and Bone Metastases
por: Zhang, Gao, et al.
Publicado: (2021)

Parathyroid hormone-related protein inhibits nitrogen-containing bisphosphonate-induced apoptosis of human periodontal ligament fibroblasts by activating MKP1 phosphatase
por: Liu, Di, et al.
Publicado: (2021)

Retracted: Analysis of the Mechanism and Safety of Bisphosphonates in Patients with Lung Cancer and Bone Metastases
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Nitrogen containing bisphosphonates associated osteonecrosis of the jaws: A review for past 10 year literature
por: Kumar, Vijay, et al.
Publicado: (2014)

Nitrogen-Containing Bisphosphonates Downregulate Cathepsin K and Upregulate Annexin V in Osteoclasts Cultured In Vitro
por: Bautista-Carbajal, Arturo, et al.
Publicado: (2023)

Impact of Molecular Subtype Conversion of Breast Cancers after Neoadjuvant Chemotherapy on Clinical Outcome
por: Lim, Siew Kuan, et al.
Publicado: (2016)

Estrogen receptor transcription and transactivation: Antitumor potential of bisphosphonates
por: Green, JR
Publicado: (2001)

Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases
por: Addison, Christina L, et al.
Publicado: (2014)

Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer
por: Hagiwara, May, et al.
Publicado: (2013)

Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany
por: Diel, Ingo, et al.
Publicado: (2020)

Effects of palliative radiotherapy and bisphosphonate usage on bone turnover marker levels in cancer patients with osteolytic bone metastases
por: Göksel, Fatih, et al.
Publicado: (2021)

Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate.
por: Dodwell, D. J., et al.
Publicado: (1990)

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases
por: Beuselinck, B, et al.
Publicado: (2012)

Bisphosphonates and parathyroid hormone analogs for improving bone quality in spinal fusion: State of evidence
por: Atesok, Kivanc, et al.
Publicado: (2020)

CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer
por: Sim, Sung Hoon, et al.
Publicado: (2017)

Radiographic changes of mandibular cortical bone in bisphosphonate drug holiday
por: Lee, Dae-Hoon, et al.
Publicado: (2022)

Farnesyl diphosphate synthase, the target for nitrogen-containing bisphosphonate drugs, is a peroxisomal enzyme in the model system Dictyostelium discoideum
por: Nuttall, James M., et al.
Publicado: (2012)

The expression of embryonic globin mRNA in a severely anemic mouse model induced by treatment with nitrogen-containing bisphosphonate
por: Otsuka, Hirotada, et al.
Publicado: (2016)

Inhibition of Osteoclast Differentiation and Bone Resorption by Bisphosphonate-conjugated Gold Nanoparticles
por: Lee, Donghyun, et al.
Publicado: (2016)

Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases
por: Matza, Louis S., et al.
Publicado: (2012)

Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).
por: Coleman, R. E., et al.
Publicado: (1988)

Design and Biological Evaluation of Delivery Systems Containing Bisphosphonates
por: Aderibigbe, Blessing, et al.
Publicado: (2016)

Utilization of bone densitometry for prediction and administration of bisphosphonates to prevent osteoporosis in patients with prostate cancer without bone metastases receiving antiandrogen therapy
por: Holt, Abby, et al.
Publicado: (2014)

Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme
por: Jena, Lynn N, et al.
Publicado: (2021)

The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
por: Migliaccio, Silvia, et al.
Publicado: (2007)

Subtrochanteric Femoral Insufficiency Fracture Following Bisphosphonate Therapy for Osseous Metastases
por: Bush, Lisabeth A., et al.
Publicado: (2015)

Comparison of the efficacy of three once-weekly bisphosphonates on bone mineral density gains in Korean women
por: Lee, Ji Hyun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9h15lotp6eu2j7gec1jfdbfbo5